Novel Case Suggests Alzheimer’s Possible in HIV+ Patients
Until now, it was thought that HIV-related inflammation protected the brain from amyloid deposition.
Until now, it was thought that HIV-related inflammation protected the brain from amyloid deposition.
Paroxetine use improved cognitive impairment and reduced inflammation in HIV patients.
The URMC-099 compound combined with antiretroviral therapy significantly reduced HIV levels.
CSF cultures were negative despite worsening meningitis infection.
Researchers are now testing whether antiretroviral drugs used to treat HIV/AIDS are effective in ALS patients.
The findings may have implications for the development of future vaccines.
The new treatment would need to be combined with other HIV drugs or antibodies.
The brain can harbor active HIV even after seemingly successful antiretroviral treatment.
Some coping strategies like substance abuse may have negative affects on overall health.
More than 50% of people with AIDS in the United States also suffer from neurological complications.